28077112|t|Prevalence and factors associated with hypertension in Burkina Faso: a countrywide cross-sectional study
28077112|a|High blood pressure (HBP) is an increasing public health issue for developing countries. HBP is an important contributing factor to many non-communicable diseases that were until very recently thought to be rare in developing countries. There is not enough evidence on its burden and risk factors in Africa. We report in this study on the prevalence and factors associated with HBP in the adult and active population of Burkina Faso from a nationally representative sample. We conducted a secondary analysis of data from the World Health Organization (WHO) Stepwise approach to Surveillance(STEPS) survey on the prevalence of major risk factors for non-communicable diseases in Burkina Faso. This survey was conducted between September 26 and November 18, 2013 and involved a nationally representative sample of 4,800 adults aged 25 to 64 years. The risk factors were identified using a binary logistic regression in STATA Version 13.1 software. The analysis was conducted on a sample of 4629 participants of whom 72.18% lived in rural areas. The overall prevalence of hypertension in Burkina Faso was 18% (95% CI: 16.19%-19.96%). In urban areas the prevalence was 24.81% (95% CI 20.21%-30.07%) and 15.37% (95% CI 13.67%-17.24%) in rural areas. Increased Body Mass Index (BMI) and older age were consistently associated with higher odds of HBP in both residential areas. In addition, being of male sex, fat intake, family history of HBP and low level of HDL cholesterol were significantly associated with increased odds of HBP in rural residents. The prevalence of hypertension is high in Burkina Faso with roughly one person in five affected. There is a predominant burden in urban areas with prevalence of ten-point percent higher compared to rural area. Modifiable risk factors should be targeted with appropriate and effective strategies to curb the rising burden of hypertension and its consequences.
28077112	0	10	Prevalence	T081	C0033105
28077112	15	22	factors	T169	C1521761
28077112	23	38	associated with	T080	C0332281
28077112	39	51	hypertension	T047	C0020538
28077112	55	67	Burkina Faso	T083	C0006409
28077112	71	104	countrywide cross-sectional study	T062	C0010362
28077112	105	124	High blood pressure	T047	C0020538
28077112	126	129	HBP	T047	C0020538
28077112	137	147	increasing	T169	C0442808
28077112	148	154	public	T098	C1257890
28077112	155	161	health	T078	C0018684
28077112	162	167	issue	T033	C0033213
28077112	172	192	developing countries	T080	C0011750
28077112	194	197	HBP	T047	C0020538
28077112	204	213	important	T080	C3898777
28077112	214	226	contributing	T052	C1880177
28077112	227	233	factor	T169	C1521761
28077112	242	267	non-communicable diseases	T047	C0012634
28077112	289	297	recently	T079	C0332185
28077112	298	305	thought	T041	C0039869
28077112	312	316	rare	T080	C0522498
28077112	320	340	developing countries	T080	C0011750
28077112	362	370	evidence	T078	C3887511
28077112	378	384	burden	T078	C2828008
28077112	389	401	risk factors	T033	C0035648
28077112	405	411	Africa	T083	C0001737
28077112	416	422	report	T170	C1317750
28077112	431	436	study	T062	C2603343
28077112	444	454	prevalence	T081	C0033105
28077112	459	466	factors	T169	C1521761
28077112	467	482	associated with	T080	C0332281
28077112	483	486	HBP	T047	C0020538
28077112	494	499	adult	T100	C0001675
28077112	504	521	active population	T098	C1257890
28077112	525	537	Burkina Faso	T083	C0006409
28077112	545	555	nationally	T092	C1555720
28077112	556	570	representative	T052	C1882932
28077112	571	577	sample	T167	C0370003
28077112	594	620	secondary analysis of data	UnknownType	C0683944
28077112	630	655	World Health Organization	T093	C0043237
28077112	657	660	WHO	T093	C0043237
28077112	662	679	Stepwise approach	T082	C0449445
28077112	683	702	Surveillance(STEPS)	T169	C0220920
28077112	703	709	survey	T170	C0038951
28077112	717	727	prevalence	T081	C0033105
28077112	731	736	major	T080	C0205164
28077112	737	749	risk factors	T033	C0035648
28077112	754	779	non-communicable diseases	T047	C0012634
28077112	783	795	Burkina Faso	T083	C0006409
28077112	802	808	survey	T170	C0038951
28077112	831	840	September	T079	C3828193
28077112	848	856	November	T079	C3828767
28077112	870	878	involved	T169	C1314939
28077112	881	891	nationally	T092	C1555720
28077112	892	906	representative	T052	C1882932
28077112	907	913	sample	T167	C0370003
28077112	923	929	adults	T100	C0001675
28077112	930	934	aged	T032	C0001779
28077112	944	949	years	T079	C0439234
28077112	955	967	risk factors	T033	C0035648
28077112	973	983	identified	T080	C0205396
28077112	992	1018	binary logistic regression	T062	C0206031
28077112	1022	1049	STATA Version 13.1 software	T073,T170	C0037585
28077112	1055	1063	analysis	T062	C0871424
28077112	1083	1089	sample	T167	C0370003
28077112	1098	1110	participants	T098	C0679646
28077112	1126	1131	lived	T082	C0337646
28077112	1135	1146	rural areas	T082	C0178837
28077112	1152	1159	overall	T080	C1561607
28077112	1160	1170	prevalence	T081	C0033105
28077112	1174	1186	hypertension	T047	C0020538
28077112	1190	1202	Burkina Faso	T083	C0006409
28077112	1216	1218	CI	T081	C0009667
28077112	1239	1250	urban areas	T082	C0178876
28077112	1255	1265	prevalence	T081	C0033105
28077112	1282	1284	CI	T081	C0009667
28077112	1316	1318	CI	T081	C0009667
28077112	1337	1348	rural areas	T082	C0178837
28077112	1350	1359	Increased	T081	C0205217
28077112	1360	1375	Body Mass Index	T201	C1305855
28077112	1377	1380	BMI	T201	C1305855
28077112	1386	1395	older age	T032	C0001779
28077112	1401	1413	consistently	T080	C0205556
28077112	1414	1429	associated with	T080	C0332281
28077112	1430	1436	higher	T080	C0205250
28077112	1445	1448	HBP	T047	C0020538
28077112	1452	1456	both	T080	C1706086
28077112	1457	1474	residential areas	T082	C1254362
28077112	1476	1487	In addition	T169	C0332287
28077112	1498	1506	male sex	T032	C0086582
28077112	1508	1518	fat intake	T201	C0489488
28077112	1520	1534	family history	T033	C0455405
28077112	1538	1541	HBP	T047	C0020538
28077112	1546	1558	low level of	T033	C0856966
28077112	1559	1574	HDL cholesterol	T109,T123	C0023822
28077112	1594	1609	associated with	T080	C0332281
28077112	1610	1619	increased	T081	C0205217
28077112	1628	1631	HBP	T047	C0020538
28077112	1635	1650	rural residents	T098	C0035962
28077112	1656	1666	prevalence	T081	C0033105
28077112	1670	1682	hypertension	T047	C0020538
28077112	1686	1690	high	T080	C0205250
28077112	1694	1706	Burkina Faso	T083	C0006409
28077112	1724	1730	person	T098	C0027361
28077112	1739	1747	affected	T080	C0205556
28077112	1760	1771	predominant	T080	C1542147
28077112	1772	1778	burden	T078	C2828008
28077112	1782	1793	urban areas	T082	C0178876
28077112	1799	1809	prevalence	T081	C0033105
28077112	1831	1837	higher	T080	C0205250
28077112	1838	1846	compared	T052	C1707455
28077112	1850	1860	rural area	T082	C0178837
28077112	1873	1885	risk factors	T033	C0035648
28077112	1896	1904	targeted	T169	C1521840
28077112	1910	1921	appropriate	T080	C1548787
28077112	1926	1935	effective	T080	C1704419
28077112	1936	1946	strategies	T041	C0679199
28077112	1959	1965	rising	T169	C0442808
28077112	1966	1972	burden	T078	C2828008
28077112	1976	1988	hypertension	T047	C0020538
28077112	1997	2009	consequences	T169	C0686907